Development of a PAK4-targeting PROTAC for renal carcinoma therapy: concurrent inhibition of cancer cell proliferation and enhancement of immune cell response
Cited by 20
Related Papers
Tissue Metabonomic Phenotyping for Diagnosis and Prognosis of Human Colorectal Cancer
|Scientific Reports|2016|64
Kaempferol induces cell cycle arrest and apoptosis in renal cell carcinoma through EGFR/p38 signaling
|Oncology Reports|2014|61
6-Gingerol induces cell-cycle G1-phase arrest through AKT–GSK 3β–cyclin D1 pathway in renal-cell carcinoma
|Cancer Chemotherapy and Pharmacology|2019|43
<p>FANCI Cooperates with IMPDH2 to Promote Lung Adenocarcinoma Tumor Growth via a MEK/ERK/MMPs Pathway</p>
|OncoTargets and Therapy|2020|43
Deubiquitinase OTUD5 modulates mTORC1 signaling to promote bladder cancer progression
|Cell Death and Disease|2022|42